[Seminar] Initiatives of the newly established "Pharmaceuticals Rapid and Stable Supply Subcommittee"
Council on Health Science "Pharmaceuticals and Medical Devices System Subcommittee" - Pharmaceutical and Medical Device Act, Real World Data, Pharmacy Functions
Our company will hold a business seminar. 【Seminar Details】 ■ Date and Time: November 25, 2025 (Tuesday) 13:30 - 15:30 (Doors open at 13:00) ■ Venue: JPI Conference Square ■ Address: 5-2-32 Minamiazabu, Minato-ku, Tokyo, Kowa Hiroo Building ■ Participation Method: In-person, live streaming, archived streaming ■ Speaker: Ken'ichi Nakayama, Chairperson of the Ministry of Health, Labour and Welfare's Health Science Council "Pharmaceuticals and Medical Devices System Subcommittee" "Subcommittee on Rapid and Stable Supply of Prescription Drugs" *For more details, please refer to the PDF document or feel free to contact us.
Inquire About This Product
basic information
**Lecture Overview** The Health Science Council's "Pharmaceuticals and Medical Devices Agency Subcommittee" primarily oversees the Pharmaceutical and Medical Device Act (a law concerning the assurance of quality, efficacy, and safety of pharmaceuticals and medical devices, etc.). A partial amendment was promulgated in May of the 7th year of Reiwa and will be implemented sequentially. The key points include strengthening the assurance of quality and safety of pharmaceuticals, enhancing the stable supply system for medical-use pharmaceuticals, creating an environment for more active drug discovery, utilizing real-world data and addressing challenges, and strengthening pharmacy functions for the proper provision of pharmaceuticals to the public. This lecture will provide a detailed explanation of the outline of the amended Pharmaceutical and Medical Device Act, as well as the initiatives of the newly established "Subcommittee for Rapid and Stable Supply of Medical-use Pharmaceuticals," which was created in conjunction with this legal amendment. **Lecture Items** ■ Overview of the 7th year of Reiwa Pharmaceutical and Medical Device Act amendment ■ Possibilities and challenges of utilizing real-world data ■ New possibilities and expectations for pharmacies ■ Rapid and stable supply of medical-use pharmaceuticals ■ Related Q&A ■ Business card and information exchange meeting
Price information
[Course Fee] 1 person: 37,450 yen (tax included) From 2 people onwards: 32,450 yen (when applying simultaneously from the same company or affiliated company) *For those belonging to local public organizations, up to 2 people can attend for 11,000 yen (tax included) However, this is limited to in-person attendance or live streaming attendance. Please ensure that the attendance format for both individuals is the same.
Delivery Time
Applications/Examples of results
For more details, please refer to the PDF document or feel free to contact us.
catalog（1）
Download All Catalogs
Company information
JPI Corporation (Japan Planning Institute) has been providing valuable information for executives and senior management involved in the execution of national policies and national projects, supporting the dissemination of state policies as a 'bridge of knowledge' between 'government', 'administration', and 'citizens' in the form of exclusive real seminars for participants for half a century, aiming to create national knowledge.